E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/30/2015 in the Prospect News PIPE Daily.

OptimizeRx completes $4.73 million private placement of common stock

Deal sells 6,011,106 shares at $0.7875 each to Luxembourg Gamma Three

By Devika Patel

Knoxville, Tenn., Sept. 30 – OptimizeRx Corp. settled a $4,733,746 private placement of stock with WPP Luxembourg Gamma Three Sarl on Sept. 24, according to an 8-K filed Tuesday with the Securities and Exchange Commission.

The company sold 6,011,106 common shares at $0.7875 apiece. The per-share price represents a 21.25% discount to the Sept. 23 closing share price of $1.00.

Proceeds will be used for working capital purposes.

Based in Rochester, Mich., OptimizeRx provides platforms to help patients better afford and comply to their medicines and health-care products, while offering pharmaceutical and health-care companies ways to expand patient awareness, access and adherence to their brands.

Issuer:OptimizeRx Corp.
Issue:Common stock
Amount:$4,733,746
Shares:6,011,106
Price:$0.7875
Warrants:No
Investor:WPP Luxembourg Gamma Three Sarl
Settlement date:Sept. 24
Stock symbol:OTCBB: OPRX
Stock price:$1.00 at close Sept. 23
Market capitalization:$25.47 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.